(Q33862523)

English

HER1-targeted 86Y-panitumumab possesses superior targeting characteristics than 86Y-cetuximab for PET imaging of human malignant mesothelioma tumors xenografts

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

HER1-targeted 86Y-panitumumab possesses superior targeting characteristics than 86Y-cetuximab for PET imaging of human malignant mesothelioma tumors xenografts (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Tapan K Nayak

1

0 references

author name string

Kayhan Garmestani

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Diane E Milenic

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Kwamena E Baidoo

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Martin W Brechbiel

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

25 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

e18198

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

copyright license

Creative Commons CC0 License

25 March 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted, dedicated to the public domain by copyright holder

0 references

Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064677

5 July 2018

Preparation, biological evaluation, and pharmacokinetics of the human anti-HER1 monoclonal antibody panitumumab labeled with 86Y for quantitative PET of carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064677

5 July 2018

PET imaging of tumor angiogenesis in mice with VEGF-A-targeted (86)Y-CHX-A″-DTPA-bevacizumab.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064677

5 July 2018

Volume-based parameter of 18)F-FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064677

5 July 2018

PET imaging of HER1-expressing xenografts in mice with 86Y-CHX-A''-DTPA-cetuximab.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064677

5 July 2018

Asbestos-induced lung diseases: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064677

5 July 2018

Mesothelioma epidemiology, carcinogenesis, and pathogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064677

5 July 2018

EGFR and PDGFR differentially promote growth in malignant epithelioid mesothelioma of short and long term survivors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064677

5 July 2018

Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064677

5 July 2018

Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064677

5 July 2018

Update on the molecular biology of malignant mesothelioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064677

5 July 2018

Use of imaging in the management of malignant pleural mesothelioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064677

5 July 2018

Advances in malignant mesothelioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064677

5 July 2018

New agents in the management of advanced mesothelioma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064677

5 July 2018

Perspectives on cancer therapy with radiolabeled monoclonal antibodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064677

5 July 2018

Targeting of HER2 antigen for the treatment of disseminated peritoneal disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064677

5 July 2018

Antibody pharmacokinetics and pharmacodynamics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064677

5 July 2018

Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064677

5 July 2018

PET imaging of (86)Y-labeled anti-Lewis Y monoclonal antibodies in a nude mouse model: comparison between (86)Y and (111)In radiolabels.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064677

5 July 2018

Systemic radiotherapy in metastatic breast cancer using 90Y-linked monoclonal MUC-1 antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064677

5 July 2018

Increased epidermal growth factor-receptor protein in a human mesothelial cell line in response to long asbestos fibers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064677

5 July 2018

Tissue and serum EGFR as prognostic factors in malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018198

21 January 2018

Epidermal growth factor receptor gene mutation, amplification and protein expression in malignant pleural mesothelioma.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018198

21 January 2018

Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018198

21 January 2018

A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018198

21 January 2018

Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018198

21 January 2018

A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018198

21 January 2018

PET for the evaluation of pleural thickening observed on CT.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064677

29 October 2018

Staging of malignant pleural mesothelioma: comparison of CT and MR imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/21464917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new and convenient method for purification of 86Y using a Sr(II) selective resin and comparison of biodistribution of 86Y and 111In labeled Herceptin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21464917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RadioimmunoPET: detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/21464917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dosimetry of copper-64-labeled monoclonal antibody 1A3 as determined by PET imaging of the torso

1 reference

https://pubmed.ncbi.nlm.nih.gov/21464917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/21464917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model

1 reference

https://pubmed.ncbi.nlm.nih.gov/21464917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malignant mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21464917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR overexpression in malignant pleural mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21464917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR expression: associations with outcome and clinicopathological variables in malignant pleural mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21464917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potentiation of high-LET radiation by gemcitabine: targeting HER2 with trastuzumab to treat disseminated peritoneal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21464917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody pharmacokinetics and pharmacodynamics

1 reference

https://pubmed.ncbi.nlm.nih.gov/21464917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malignant pleural mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21464917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased expression of epidermal growth factor receptor in rat pleural mesothelial cells correlates with carcinogenicity of mineral fibres

1 reference

https://pubmed.ncbi.nlm.nih.gov/21464917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0018198

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

2011PLoSO...618198N

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33862523&oldid=1971402772"